Press kit

BenevolentAI is a leading developer of advanced artificial intelligence technologies that unlock the value of multimodal data, surface novel insights, and accelerate biomedical discovery.

Through the combined capabilities of its AI platform and its scientific expertise the Company is developing an inhouse drug pipeline of high-value assets.